Acarix AB

ACARIX

(NasdaqOMXS)

sek 20,50 <%= Resources.Global.txtDown %>

Opdateret 15:26:03

Ændring %	-1,44%
Ændring	-0,30
Volume	2
Høj	SEK 20,50
Lav	SEK 20,50
Åben	SEK 20,50
ISIN	SE0009268717
Seneste luk	SEK 20,80
# af aktier	23,03M
Markedsværdi	472,06M SEK

I dag

Market closed

Markedet er lukket, åbner klokken 09:00


Kursudvikling	Seneste	1 uge	1 måned	3 mdr	6 mdr	1 år

	20,50	-2,4%	-2,4%	4,1%	-10,1%	0,0%

Få fuld adgang til ordredybde på
Acarix AB
Klik her

Dansk
Engelsk
Fondsbørsmeddelelser

	05 jul	Acarix Receives First German Commercial Order For CADScor®System For Early Detection Of Coronary Artery Disease From Private Cardiology Clinic In Berlin

	13 jun	Acarix Receives First Commercial Order For CADScor®System For Early Detection Of Coronary Artery Disease From Danish Hospital

	29 maj	Acarix CADScor®System - an advanced, easy to use, frontline test to rule out Coronary Artery Disease with high accuracy. On display at British Cardiovascular Society Meeting in Manchester, June 5-7.

	24 maj	Announcement from Acarix's annual general meeting

	24 maj	Acarix publishes the Interim Report for the period January - March 2017

	10 maj	Acarix awarded Danish Design Award 2017 for its innovative heart disease testing device; CADScor®System

	24 apr	Notice of Annual General Meeting in Acarix AB

	18 apr	Acarix publishes the 2016 Annual Report

	17 mar	Acarix CADScor®System multi-center trial results confirms previous preliminary results of CADScor®System ruling out CAD with 97% negative predictive value

	23 feb	Acarix presents Year-end Report, January - December 2016

Flere nyheder

Få fuld adgang til mæglerstatistik på
Acarix AB
Klik her

Følg os:

Facebook

Twitter

Copyright Euroinvestor A/S 2017 Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.

13. juli 2017 20:55:12
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris

Acarix AB

Nyheder om Acarix AB

Firmaprofil